W135 meningococcal disease in Africa
2003

W135 Meningococcal Disease in Africa

publication Evidence: moderate

Author Information

Author(s): Pollard Andrew J., Santamaria Maria, Maiden Martin C.J.

Primary Institution: University of Oxford

Hypothesis

What are the factors contributing to the ongoing epidemics of meningococcal disease in Africa?

Conclusion

A comprehensive vaccine strategy is needed to control epidemic meningococcal disease in Africa, particularly for non-serogroup A strains.

Supporting Evidence

  • Epidemic meningococcal disease has been a problem in Africa for about 100 years.
  • Mass vaccination with serogroup A/C vaccines has been used but is questioned for its efficacy.
  • Recent findings show that serogroup W135 meningococci are increasingly responsible for outbreaks.

Takeaway

Meningococcal disease is a big problem in Africa, and we need better vaccines to stop it from spreading.

Methodology

The workshop explored epidemiological studies and vaccine strategies for meningococcal disease in Africa.

Limitations

The workshop did not address the urgent need for vaccines to control epidemics in the immediate future.

Participant Demographics

Participants included researchers and contributors from various institutions and countries, including the University of Oxford and the World Health Organization.

Digital Object Identifier (DOI)

10.3201/eid0911.020727

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication